Stericycle, Inc. (SRCL)

Stericycle Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-19.5	-21.4	56	-27.8	-57.3	-346.8
Depreciation & Amortization	215.2	216.5	232.5	223.9	233.5	272.8
Share-Based Compensation	29.2	33.4	25.1	27.1	25.5	17.1
Other Operating Activities	-85.6	14.8	-113.4	79.9	328.5	304.9
Operating Cash Flow	139.3	243.3	200.2	303.1	530.2	248
Operating Cash Flow Growth	-51.72%	21.53%	-33.95%	-42.83%	113.79%	49.67%
Capital Expenditures	-138	-131.3	-132.2	-116.9	-119.5	-194.2
Acquisitions	69.7	84.6	46.7	24.5	498.9	86.4
Other Investing Activities	2.2	2.9	0.9	2.3	2	3.8
Investing Cash Flow	-66.1	-43.8	-84.6	-90.1	381.4	-104
Share Issuance / Repurchase	-6.7	-5.2	-5.6	-3.4	-0.4	19.9
Debt Issued / Paid	-92.8	-213.7	-105.1	-203.6	-890.7	-160.8
Other Financing Activities	-	-1.5	-0.3	-0.9	-1.4	-0.7
Financing Cash Flow	-99.5	-220.4	-111	-207.9	-892.5	-141.6
Exchange Rate Effect	-2.7	0.2	-4.2	-2.8	-0.5	-2
Net Cash Flow	-29	-20.7	0.4	2.3	18.6	0.4
Free Cash Flow	1.3	112	68	186.2	410.7	53.8
Free Cash Flow Growth	-99.17%	64.71%	-63.48%	-54.66%	663.38%	54.15%
Free Cash Flow Margin	0.05%	4.21%	2.51%	7.03%	15.35%	1.63%
Free Cash Flow Per Share	0.01	1.21	0.74	2.03	4.49	0.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).